Bcr Diagnostics Middletown, RI - 02842

Bcr Diagnostics is categorized under Commercial Research Laboratory in Middletown, RI and active since 2007.

Bcr Diagnostics was established in 2007, and today employs 1 to 4, earning Unknown per year. This is a Commercial Research Laboratory business, which does work in the B2B market, and is classified as a Commercial Research Laboratory, under code number 5417110 by the NAICS.

If you are seeking more information, feel free to contact Boris Rotman, Executive Vice President at the company’s single location by writing to 184 John Clarke Road, Middletown, Rhode Island RI 02842 or by phoning (401) 849-9957. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bcr Diagnostics
Contact Person: Boris Rotman, Executive Vice President
Address: 184 John Clarke Road, Middletown, Rhode Island 02842
Phone Number: (401) 849-9957
Website Address: bcrbiotech.com
Annual Revenue (USD): Unknown
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Research Laboratory
SIC Code: 8731
NAICS Code: 5417110
Share This Business:

Bcr Diagnostics was started in 2007 to provide professional Commercial Research Laboratory under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Boris Rotman, Executive Vice President for inquiries that concern Bcr Diagnostics by calling the company number (401) 849-9957, as your correspondence is most welcome. Additionally, the physical location of the single location of Bcr Diagnostics can be found at the coordinates 41.49854,-71.28455 as well as the street address 184 John Clarke Road in Middletown, Rhode Island 02842.

For its online presence, you may visit Bcr Diagnostics’s website at bcrbiotech.com and engage with its social media outlets through on Twitter and on Facebook.